Wound Healing Technologies Corp.

Wound Healing Technologies Corp. is a privately held company founded in 2005, with its headquarters located in Brooklyn, New York, United States. The company reportedly has 11-50 employees and an estimated annual revenue between $5 million and $10 million.

The company operates in the hospital and healthcare industry, specializing in Negative Pressure Wound Therapy (NPWT). Wound Healing Technologies provides NPWT products, including their "Tzoar 207 NPWT System" and related dressings, alongside comprehensive support services. These services are offered to nursing homes nationwide and encompass device training, prompt delivery of equipment and supplies, and 24/7 clinical support for patient care.

Wound Healing Technologies Corp. primarily appears to be an entity asserting intellectual property rights, given its litigation posture. The company has one tracked case as a plaintiff and zero as a defendant. This activity suggests it may operate as a non-practicing entity (NPE) or a patent assertion entity, asserting patents rather than defending against infringement claims. The single tracked case is filed in the Western District of Texas.

The company's notable litigation involves Wound Healing Technologies Corp. v. Solventum Corporation, filed on November 15, 2024, in the Texas Western District Court. This case centers on patent infringement, specifically concerning U.S. Patent No. 10,639,404, which describes wound dressings for administering negative pressure wound therapy. Solventum Corporation, a significant entity in the wound care market, has also filed an Inter Partes Review (IPR2025-01042) challenging this patent.